Abstract:Interleukin-30 (IL-30), or IL-27p28, is the. subunit of IL-27 constructed by Epstein-Barr virus-induced gene 3 (EBI3) and IL-27p28 binding via noncovalent bonds. IL-30 can be independently secreted and function independently of IL-27. Recent studies demonstrated IL-30 could concurrently antagonize T helper 1 (Th1) and Th17 responses and might have therapeutic implications for controlling autoimmune diseases. However, no reports have stated an efficient method to generate a relatively large quantity of IL-30. In this study, an Escherichia coli expression system for the rapid expression of the mouse IL-30 is developed. For the first time, IL-30 was expressed in a form of soluble fusion protein and purified using a method of simple affinity chromatography. In order to avoid the impact of minor codons on expressing eukaryotic protein in E. coli and to improve the expression quantity, the nucleotide sequence of IL-30 was optimized. The optimized gene sequence was then subcloned into the pET-44a(+) vector, which allowed expression of IL-30 with a fusion tag, NusA. The vector was transformed into E. coli and the expressed fusion protein, NusA-IL-30, was purified by Ni chromatography. Then the fusion tag was removed by cleavage with thrombin. The purity of purified IL-30 was identified using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) as well as high-performance liquid chromatography (HPLC) and the purity was up to about 92%. The yield of IL-30 was 8.95 mg from 1 L of bacterial culture. Western blot confirmed the identity of the purified protein. The recombinant IL-30 showed its biological activity by inhibiting Th17 differentiating from naive CD4(+) T cells. Therefore, this method of express and purifying IL-30 provides novel procedures to facilitate structural and functions studies of IL-30.

Expression and Purification of Tag-removed Human IL37 by Digestion on Beads in Escherichia Coli.

Expression, Purification of IL-38 in Escherichia Coli and Production of Polyclonal Antibodies.

Soluble expression and purification of bioactive interleukin 33 in E. coli

Purification and Characterization of Non-Fusion Recombinant Human Interleukin-18 Expressed in E. Coli

Soluble Expression and Purification of the Functional Interleukin-30 Protein in Escherichia coli

Preparation of Recombinant Human IL-17A and IL-17F and Determination of Their Bioactivities

Purification and bioactiveity detection of recombinant human interleukin 17

Expression,Purification and Identification of Recombinant Human Interleukin-13 in Escherichia Coli

[High Level Expression, Purification and Cytotoxicity of IL-10(18-57)-PE40].

Expression, refolding and purification of a human interleukin-17A variant

Expression, Purification, and Functional Characterization of Recombinant Human Interleukin-7

A novel self-cleavable tag Zbasic–∆I-CM and its application in the soluble expression of recombinant human interleukin-15 in Escherichia coli

Expression, purification, and biological characterization of recombinant human interleukin-31 protein

Expression and Identification of Recombinant Human Interleukin 7 Product in Escherichia Coli

Expression, Purification and Characterization of Soluble Human Interleukin-6 Receptor Α-Chain and Its Mutant Protein in Escherichia Coli

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Recombinant expression, downstream optimization, and therapeutic evaluation of recombinant human interleukin-37 for cancer therapy

Codon Optimization, Expression, Purification, and Functional Characterization of Recombinant Human IL-25 in Pichia Pastoris

A Method for Obtaining the High Purity of Reeombinant Human Interleukin-8 from Escherichia Coli

Expression of Human Interleukin-33 and Studies on Its Biology Function

High Level Expression and Purification of Active Recombinant Human Interleukin-8 in Pichia Pastoris.